Qube Research & Technologies (QRT)
RNTX

Qube Research & Technologies (QRT)’s Rein Therapeutics RNTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,264
Closed -$26K – 3053
2021
Q3 		$26K Buy
+1,264
New +$27.7K ﹤0.01% 1945
2021
Q2 		– Sell
-618
Closed -$18K – 2886
2021
Q1 		$18K Sell
618
-2,768
-82% -$94.8K ﹤0.01% 1821
2020
Q4 		$70K Sell
3,386
-7,827
-70% -$196K ﹤0.01% 1674
2020
Q3 		$289K Buy
11,213
+9,644
+615% +$227K ﹤0.01% 1262
2020
Q2 		$37K Buy
+1,569
New +$25.6K ﹤0.01% 1632

Other funds holding RNTX

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return